Holen Sie sich die Stockscreener-App
72.65
0.62%
0.45
Handel nachbörslich:
72.65
Schlusskurs vom Vortag:
$72.20
Offen:
$71.96
24-Stunden-Volumen:
389.71K
Relative Volume:
0.53
Marktkapitalisierung:
$3.65B
Einnahmen:
$379.25M
Nettoeinkommen (Verlust:
$-77.34M
KGV:
-45.06
EPS:
-1.6122
Netto-Cashflow:
$-27.87M
1W Leistung:
+3.76%
1M Leistung:
-0.90%
6M Leistung:
+67.20%
1J Leistung:
+88.90%
1-Tages-Spanne:
$71.23
$73.23
1-Wochen-Bereich:
$68.34
$73.23
52-Wochen-Spanne:
$36.88
$78.54
Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile
Firmenname
Mirum Pharmaceuticals Inc
Sektor
Branche
Telefon
650-667-4085
Adresse
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
Vergleichen Sie MIRM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MIRM
Mirum Pharmaceuticals Inc
|
72.65 | 3.63B | 379.25M | -77.34M | -27.87M | -1.6122 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-24 | Eingeleitet | TD Cowen | Buy |
| 2025-08-11 | Fortgesetzt | Stifel | Buy |
| 2025-05-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-04-17 | Eingeleitet | Stifel | Buy |
| 2023-12-18 | Bestätigt | H.C. Wainwright | Buy |
| 2023-11-20 | Fortgesetzt | JP Morgan | Overweight |
| 2023-11-13 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-10-17 | Fortgesetzt | Evercore ISI | Outperform |
| 2023-09-20 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-09-01 | Eingeleitet | Citigroup | Buy |
| 2021-09-20 | Eingeleitet | JP Morgan | Overweight |
| 2020-08-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2020-08-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-07-31 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-25 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-08-12 | Eingeleitet | Citigroup | Buy |
| 2019-08-12 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-12 | Eingeleitet | Guggenheim | Buy |
| 2019-08-12 | Eingeleitet | ROTH Capital | Buy |
| 2019-08-12 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Mirum Pharmaceuticals Inc Aktie (MIRM) Neueste Nachrichten
Why analysts remain bullish on Mirum Pharmaceuticals Inc. stockProfit Target & Daily Oversold Bounce Ideas - newser.com
Why Mirum Pharmaceuticals Inc. stock remains undervaluedRate Cut & Safe Capital Growth Stock Tips - newser.com
Is Mirum Pharmaceuticals Inc. stock overvalued by current metricsWatch List & Real-Time Volume Trigger Notifications - newser.com
Published on: 2025-11-01 02:12:11 - newser.com
Mirum Pharmaceuticals Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
Investors Aren't Buying Mirum Pharmaceuticals, Inc.'s (NASDAQ:MIRM) Revenues - 富途牛牛
What analysts say about Mirum Pharmaceuticals Inc stockMarket Profile Overview & High Return Trading Tips - earlytimes.in
How currency fluctuations impact Mirum Pharmaceuticals Inc. stock2025 Analyst Calls & Free Community Supported Trade Ideas - newser.com
Will Mirum Pharmaceuticals Inc. see short term momentum2025 Earnings Surprises & Community Consensus Trade Alerts - newser.com
Emerald Mutual Fund Advisers Trust Takes $11.07 Million Position in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
How to use Fibonacci retracement on Mirum Pharmaceuticals Inc.July 2025 Selloffs & AI Driven Price Predictions - newser.com
Published on: 2025-10-31 03:46:47 - newser.com
Using RSI to spot recovery in Mirum Pharmaceuticals Inc.July 2025 Analyst Calls & Fast Entry High Yield Tips - newser.com
Will breakout in Mirum Pharmaceuticals Inc. lead to full recoveryTrade Volume Report & Short-Term High Return Ideas - newser.com
Is it time to cut losses on Mirum Pharmaceuticals Inc.Jobs Report & High Accuracy Swing Entry Alerts - newser.com
How to build a custom watchlist for Mirum Pharmaceuticals Inc.2025 Biggest Moves & AI Driven Stock Reports - newser.com
Published on: 2025-10-31 01:07:37 - newser.com
Published on: 2025-10-30 23:29:10 - newser.com
Emerald Advisers LLC Acquires Shares of 305,766 Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Is Mirum Pharmaceuticals Inc. stock supported by strong cash flowsIPO Watch & Free Weekly Chart Analysis and Trade Guides - newser.com
Will Mirum Pharmaceuticals Inc. (08D) stock keep high P E multiplesJuly 2025 Summary & Comprehensive Market Scan Reports - newser.com
Mirum Pharmaceuticals Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
AlphaQuest LLC Sells 12,797 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Published on: 2025-10-29 01:58:20 - newser.com
Published on: 2025-10-29 01:50:33 - newser.com
Mirum Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025 - BioSpace
Published on: 2025-10-28 04:35:21 - newser.com
Published on: 2025-10-28 02:45:58 - newser.com
Published on: 2025-10-28 00:12:15 - newser.com
Published on: 2025-10-27 23:28:31 - newser.com
Can Mirum Pharmaceuticals Inc. (08D) stock surprise markets with earningsJuly 2025 Pullbacks & Short-Term High Return Ideas - Fundação Cultural do Pará
Finanzdaten der Mirum Pharmaceuticals Inc-Aktie (MIRM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):